| |
|
|
| |
| |
| |
Monday Morning Messages
|
| |
8th July 2024
|
|
|
|
|
|
| |
|
| |
|
|
|
|
|
| Dominic Kelly wins Tessa John Memorial Award |
| |
|
Dr. Dominic Kelly (pictured above on the far left), BRC consultant in paediatrics and clinical vaccinology at the Oxford Vaccine Group, has won the Tessa John Memorial Award for Outstanding Contributions to Children's Research. Dominic leads research on vaccines for children and is an expert on pertussis vaccines and immunity. Tessa worked for many years in children’s research at Oxford Vaccine Group and later the local clinical research network. She died in 2016 and this annual award is given in her name to researchers working on child health research from across the Thames Valley. Tessa’s parents and her three sons attended the ceremony last week and her father Richard (pictured third from left) presented the award. Emma Gammin (pictured second from left), Team Leader in Women’s and Children's Research, at the Royal Berkshire NHS Foundation Trust, was the other winner of the joint award.
|
|
|
|
Our researchers in the news
|
| |
|
|
|
|
|
Research led by Professor Philip Goulder, which shows that boys are born with higher natural resistance to HIV, has been published by online website Scidev.net. As part of the study, four male infants have been identified who have achieved HIV cure/remission – ie maintained undetectable levels of HIV in the blood, even without therapy. The online platform shares news, views and analysis on science and technology for global development, has shared the research. |
|
|
|
|
|
|
|
|
RSV vaccines approved for older adults have been tied to a very slight risk of Guillain-Barré syndrome, however US health officials still recommend that the elderly are immunised in consultation with their doctors, as the benefits outweigh this slightly increased risk. Livescience.com, a trusted online resource for scientific news, published the article with expert comment from Dr. Simon Drysdale, a paediatric infectious disease specialist in the Oxford Vaccine Group. |
|
|
|
|
| |
| |
|
|
|
|
|
|
|
| Not even the wet British weather could dampen spirits at this year's Garden Party which was held at St.Hilda's College last Friday. It was a wonderful to see so many people from across the research groups on the lawns and in deckchairs enjoying prosecco, brownies, ice cream, and great banter! A selection of photographs is available to view via the link below. |
|
|
|
End of financial year deadlines
|
| |
|
|
|
|
|
| The University’s financial year end (31st July 2024) is fast approaching. In order to ensure that your payments are included in the end of year payment run, please could you ensure you meet the deadlines in the table above. If you have any queries please reach out to: finance@paediatrics.ox.ac.uk |
|
|
|
|
|
|
| Briefing on new Oxford traffic filters |
| |
|
A briefing will take place on Tuesday 23rd July for University staff looking to find out more about the new traffic filter trial, which is due to start in November 2024, once Botley Road has reopened. The briefing will explain what is changing and how you could be affected. This will be a virtual event via Teams from 12.30-1.30pm, facilitated by the Sustainable Travel team in Estates Services. It will include a Q&A session. To sign up, visit the Travel website via the link below.
|
|
|
|
|
| |
| |
|
|
|
|
| Management meeting Trinity 2024 |
| |
|
| The senior management team for the Department of Paediatrics met on 16th June to discuss the operational and strategic direction of Paediatrics. The minutes of the meeting are available to view via the link below. |
|
|
|
|
| |
| |
|
|
|
|
| Open Research Position Statement |
| |
|
| The University’s Open Research Position Statement, approved by Research and Innovation Committee on 6 June 2024, is now available via the link below. The Statement provides a definition of open research (acknowledging that this is an evolving area) and related guidance and sets out broad expectations and responsibilities of researchers and the University. It summarises a range of good open research practices, recognising that the application of such practices will vary across different research disciplines. The Statement also signposts to existing related University policies, funder policies and support services within the University. |
|
|
|
|
| |
| |
|
|
|
|
|
|
The process for submitting research projects for ethics review is changing soon to a new system online called Worktribe. It will completely replace the previous offline and email-based process, however, any Word/paper applications already in process when the system goes live for a department can continue to follow the offline process during the initial one-month transition period.
There will be a phased roll-out of the new system:
- On Monday 5 August, the system will launch for use by the Medical Sciences Departments of Psychiatry, Clinical Neurosciences, and OxICPTR. Researchers will be able to use either Worktribe or the current system.
- One month after that day, these departments will need to submit their research ethics applications purely through the Research Ethics System (Worktribe).
- All other Medical Sciences and MPLS departments will begin using Worktribe in October.
|
|
|
|
|
| |
| |
|
|
|
|
| Open Access Publications Policy amended |
| |
|
The University of Oxford Open Access Publications Policy, and University Statute XVI which covers intellectual property rights, have now been updated to incorporate rights retention. This re-affirms the University’s preference for the green or self-archiving route to open access. From 14 October 2024, by virtue of their employment and without requiring any action on their part, employees at the University provide the rights to make author accepted manuscript versions of their articles and conference proceedings available under a Creative Commons Attribution Licence (CC BY 4.0) at the point of publication.
To utilise rights retention (https://openaccess.ox.ac.uk/rights-retention) authors can simply deposit the accepted manuscript of their work to ORA, the University repository, and the repository team will make it available once it has been published. Authors wishing to opt-out will be able to do so on a work-by-work basis when depositing their papers via Symplectic Elements. |
|
|
|
|
| |
| |
|
|
|
|
|
| 10 days paid leave for training |
| |
|
The Department has recently adapted its Professional Development scheme policy to include 10 days of leave for training and development. As part of this policy, staff are able to ask for ten days (pro-rata) per academic year, which will be paid time off for training. Dedicating time to professional development will deepen and expand your professional skill sets. It will enhance your current role, broaden your career horizons and equip you for the journey ahead. There is no obligation to grant more paid time off than the ten days, or to pay for the costs of any training but employees are entitled to have eligible requests considered.
All detail is contained in the policy which can be accessed via the link below.
|
|
|
|
|
|
|
|
|
Date: Tuesday 9 July
Time: 2pm – 4pm
Venue: In person, Kavli Institute
Who do you need to engage with in the policy world to achieve impact? In this workshop, we will help answer this and other questions by equipping Medical Sciences researchers and DPhil students, and professional services staff to identify and map the people and groups who influence or are impacted by their research, when it comes to policy engagement. Using stakeholder analysis frameworks and interactive exercises, participants will learn to identify and categorise their relevant audiences across government agencies and other pertinent policy actors. |
|
|
|
|
| |
| |
|
|
|
|
| Extracellular Vesicles: biodistribution, pharmacokinetics, and immunogenicity |
| |
|
12 July 2024 | IDRM Seminar Rooms 1&2 | 3pm
Dr. Kenneth W. Witwer is an associate professor of molecular and comparative pathobiology and neurology at the Johns Hopkins University School of Medicine. His research focuses on extracellular vesicles, RNA-mediated regulation, biomarker discovery, and therapeutic modulation of innate and intrinsic defenses. His group is particularly interested in neurodegenerative diseases including the HIV-associated neurocognitive disorders, Alzheimer’s, and Parkinson’s. The talk will be followed by networking drinks. |
|
|
|
|
| |
| |
|
|
|
|
| Challenges in Meta Analysis: My journey and solutions |
| |
|
17 July 2024 | Online Only | 1pm
Yiru Chen, DPhil student at the Department of Paediatrics, has with an undergraduate master's degree in Mathematics from Imperial College London. Her research interests lie in the clinical application of mathematical models and machine learning methods. She will talk about her journey and solutions at this meeting of the Paediatric Analysis Network. |
|
|
|
|
| |
| |
|
|
|
|
| New Therapeutic Approaches in Translational Mental Health |
| |
|
16 September 2024 | Maths Institute | All day
This in-person conference is hosted by the Oxford Health BRC and sponsored by the UK Mental Health Mission. The event aims to bring together industry, academic & clinical researchers, the regulator and government research funding organisations to discuss the current challenges facing therapeutic development. The overall objective is to forge collaborations that can increase capacity and capability through partnerships to deliver paradigm changes in translational mental health research. The event includes keynotes, lightning talks, roundtable discussion and industry led workshop sessions by Angelini Pharma, Big Health, Boehringer Ingelheim, Karuna Therapeutics and Reckitt Benckiser. |
|
|
|
|
| |
| |
|
|
|
|
| Why are so many of us burnt out, and what we can do about it? |
| |
|
26 September 2024 | Online only | Seminar 11-12; Workshop 13.30 to 15.00
Why do ever more of us find it so hard to find a good balance between life and work? The dramatic rise of work-related suffering is clearly not the problem of just a handful of people who are bad at time management.
This seminar will explore some of the deeper cultural reasons for why we are all so burnt out and offer some practical, actionable advice on what we can do about our exhaustion and how we can re-learn how to thrive.
Sign up for the Seminar here: https://forms.office.com/e/0cyFgdacJp
Sign up for the workshop here: https://forms.office.com/e/vwFNxaUq37 |
|
|
|
|
| |
| |
|
Can you help these trials?
|
| |
|
|
|
|
|
| Oxford Vaccine Group would like to invite you to take part in a study investigating how two common respiratory germs alter the environment in your nose and impact human health. The knowledge gathered in this project could be used to help develop new interventions such as anti-virus agents and drugs targeting the host body response. If you are 18 to 55 years old, you may be eligible to take part. We will provide reimbursement for your time, inconvenience and travel. The study duration is approximately 10 weeks. If you would like to find out more, please read the Participant Information Sheet. If you are interested in joining the study, please visit the Pre-screening Questionnaire via the link below. |
|
|
|
|
|
|
|
| We need volunteers for a new vaccine against Marburg virus |
| |
|
| If you are aged 18 to 55 years old and in good health, then you may be eligible to take part in a study investigating a new vaccine against Marburg virus. All participants will be reimbursed up to £1290 for their time, inconvenience, and travel. For further information please click on the link below. Here is a link to pre-screening questionnaire: Pre-screening Questionnaire or contact Oxford Vaccine Group with any questions: Email: info@ovg.ox.ac.uk Tel: 01865611400. |
|
|
|
|
|
|
|
|
|
| Oxford Vaccine Group would like to invite you to take part in a study in a challenge study to find a vaccine against malaria. The total study participation time is 18 months. If you would like any further information regarding the study please contact info@ovg.ox.ac.uk, or call 01865 611400 |
|
|
|
|
|
|
|
|
|
| Oxford Vaccine Group is looking for volunteers to help us understand how our immune systems respond to repeated infection with malaria. By taking part in this challenge study, you could help the research aimed at preventing hundreds of thousands of child deaths. If you are aged 18 to 45 years old, in good health and live in the Thames Valley, then you may be eligible to take part in the BIO-004 study. All participants will be reimbursed for their time, inconvenience and travel up to £9,100. |
|
|
|
|
|
|
|
|
|
